Dosing is one of the most perplexing issues facing the CBD and cannabinoid industry. We all know the medical adage, start low and go slow. But what if a client/consumer uses CBD for a specific condition? Perhaps your CBD brand targets a certain demographic. Unique conditions require precise solutions. Companies that adopt a one-size-fits-all policy toward dosing are bound to disappoint their fan base. Cannabinoids may exhibit biphasic effects, meaning a low dose affects the consumer in an opposite way compared to a high dose. Administration route and product composition also affect dosing. Certain individuals may even be deficient in natural cannabinoids. This panel explores a range of common conditions and the CBD doses required to address them.

source